Moderna has continued to underperform the Nasdaq Composite over the past year, and analysts remain cautious about the stock’s ...

Moderna (MRNA) slipped about 6% after an FDA official said future vaccine approvals will face tougher scrutiny, a shift tied ...

Shares of Moderna, Inc. (NASDAQ:MRNA) are trading lower Monday following reports suggesting tighter controls on how vaccines gain approval.

Moderna (MRNA) stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return. The company’s value has increased by approximately $1.2 billion over ...

Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business ...

The shares trade with liquidity of less than $1 million per day, while Schott AG retains a 77% stake. RBC applied a 9x 2027E EBITDA multiple, incorporating a 15% liquidity discount and 10% discount ...

The memo, written by FDA chief medical and scientific officer Vinay Prasad, reviewed 96 pediatric deaths and concluded that ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...

Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the February 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

Moderna ($MRNA) steps into Thursday’s analyst day with more pressure than momentum. The stock is down more than 40% this year ...

Major U.S. equities indexes lost ground Monday afternoon, as shares of tech and cryptocurrency-related companies pulled back.

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:00 AM ESTCompany ParticipantsJames Mock - Chief ...